Work

Peptide CIGB‐552 has a synergistic effect on CFTR‐F508del when combined with elexacaftor/tezacaftor/ivacaftor triple therapy for cystic fibrosis

Year: 2025

Type: article

Source: British Journal of Pharmacology

DOI: 10.1111/bph.70169

Authors: Benjamin Simonneau, Stéphanie Simon, Bénédicte Duriez, Aurélie Guguin, Frédéric Becq, Sandra Mirval, Christelle Coraux, Fanny Degrugillier, Bruno Costes, Maribel G. Vallespi, Pascale Fanen, Abdel Aissat

Institutions: Inserm, Université Paris-Est Créteil, Institut Mondor de Recherche Biomédicale, Université de Poitiers, Physiopathologie et Régulation des Transports Ioniques, Pathologies Pulmonaires et Plasticité Cellulaire, Université de Reims Champagne-Ardenne, Centro de Ingeniería Genética y Biotecnología, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Institut National de la Santé et de la Recherche Médicale, Association Vaincre la Mucoviscidose, Chancellerie des Universités de Paris

Awards: G5403014512, G7954519292, G8800098196

OpenAlex ID: W4413138614

FWCI:

Cites: 59

Cited by:

Related to: 10